Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Pimrapat Gebert"'
Autor:
Pimrapat Gebert, Maria Margarete Karsten, Anna Maria Hage, Adam David Dordevic, Ulrike Grittner
Publikováno v:
Trials, Vol 25, Iss 1, Pp 1-9 (2024)
Abstract Background With an increasing collection of patient-reported outcomes (PROs) to measure health-related quality of life (HRQoL) in oncological patients, there is still a lack of standardised strategies on how to interpret and use these data i
Externí odkaz:
https://doaj.org/article/8e3f5ef9e1a144a5b0e86c3b9a042f69
Autor:
Aino Ritva Weyers, Gabriel von Waldenfels, MD, Pimrapat Gebert, PhD, Wolfgang Henrich, MD, PhD, Larry Hinkson, MBBS, MD, MRCOG, FRCOG
Publikováno v:
AJOG Global Reports, Vol 4, Iss 2, Pp 100326- (2024)
BACKGROUND: Postpartum hemorrhage is a significant cause of both maternal morbidity and mortality worldwide and is increasing in incidence. This study aimed to assess improvement and identify shortcomings in trainee performance in different simulatio
Externí odkaz:
https://doaj.org/article/cccfb31f4ebd49cda1237e667b0fd501
Autor:
Pia S. Sperber, Pimrapat Gebert, Leonie H.A. Broersen, Anna Kufner, Shufan Huo, Sophie K. Piper, Bianca Teegen, Peter U. Heuschmann, Harald Prüss, Matthias Endres, Thomas G. Liman, Bob Siegerink
Publikováno v:
Brain, Behavior, & Immunity - Health, Vol 34, Iss , Pp 100705- (2023)
Background: Anti-NMDA-receptor GluN1 antibodies (NMDAR1-abs) are present in an autoimmune encephalitis with severe neuropsychiatric symptoms. We aimed to estimate the impact of serum NMDAR1-abs on depressive symptoms years after first-ever ischemic s
Externí odkaz:
https://doaj.org/article/4d0c1842851e4139958eeef248ef2aff
Publikováno v:
Cancer Medicine, Vol 12, Iss 7, Pp 8662-8675 (2023)
Abstract Background Fragmented and complex healthcare systems make it difficult to provide continuity of care for patients with advanced cancer near the end of life. Nurse‐based cross‐sectoral navigation support has the potential to increase pati
Externí odkaz:
https://doaj.org/article/a4be6ccfead5427b994bbe8ecef4c62d
Autor:
Anna Maria Hage, Pimrapat Gebert, Jens-Uwe Blohmer, Elham Hedayati, Dorothee Speiser, Maria Margarete Karsten
Publikováno v:
Cancers, Vol 16, Iss 4, p 738 (2024)
Data are scarce on the role of pathogenic germline variants in BRCA1 and BRCA2 (gBRCAm) in subtype-specific survival in young women who develop breast cancer under the age of 40. This retrospective, real-world cohort study assessed the distant diseas
Externí odkaz:
https://doaj.org/article/b594a6514d6b49899d6c4a6938025f1f
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-13 (2022)
Abstract Purpose Given the psychosocial burdens patients in advanced stages of cancer face, innovative care concepts are needed. At the same time, such vulnerable patient groups are difficult to reach for participation in intervention studies and ran
Externí odkaz:
https://doaj.org/article/52ef6b028b444ce6825c604f08341b0c
Autor:
Adrian Alexander Marth, Timo Alexander Auer, Gergely Bertalan, Pimrapat Gebert, Timo Kirchenberger, Dominik Geisel, Bernd Hamm, Sarah Keller
Publikováno v:
PLoS ONE, Vol 18, Iss 11 (2023)
Externí odkaz:
https://doaj.org/article/cc9bd8586dad4327b670e897bc2f5052
Autor:
Maria Margarete Karsten, Friedrich Kühn, Therese Pross, Jens-Uwe Blohmer, Anna Maria Hage, Felix Fischer, Matthias Rose, Ulrike Grittner, Pimrapat Gebert, Julia Ferencz, Luis Pauler, Clara Breidenbach, Christoph Kowalski, on behalf of the PRO B Steering Board
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-9 (2021)
Abstract Background Despite the progress of research and treatment for breast cancer, still up to 30% of the patients afflicted will develop distant disease. Elongation of survival and maintaining the quality of life (QoL) become pivotal issues guidi
Externí odkaz:
https://doaj.org/article/e3fe8bd4bef046f78697eb2ee9833165
Autor:
Pimrapat Gebert, Adam David Dordevic, Robert Roehle, Anna Maria Hage, Maria Margarete Karsten
Publikováno v:
Data in Brief, Vol 43, Iss , Pp 108347- (2022)
Patient-reported outcomes are information about health status and health-related quality of life collected directly from patients. The data in this publication contain the first assessment of patient-reported outcomes (PROs) from real-life measuremen
Externí odkaz:
https://doaj.org/article/18a4391b5ccb460e80d31654599a5e61
Publikováno v:
BMC Medical Research Methodology, Vol 21, Iss 1, Pp 1-11 (2021)
Abstract Background Patient-reported outcome measures (PROMs) are commonly-used surrogates for clinical outcomes in cancer research. When researching severe diseases such as cancer, it is difficult to avoid the problem of incomplete questionnaires fr
Externí odkaz:
https://doaj.org/article/465314eddd1043a3b93bbe291bbe8af8